MLAB
Mesa Laboratories Inc
134.00$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.6% | 37.5% | 37.9% | 36.0% | 38.7% | 36.7% | 38.2% | 45.4% | 38.5% | 35.8% | 26.8% | 35.1% | 34.0% | |
| 60.4% | 62.5% | 62.1% | 64.0% | 61.3% | 63.3% | 61.8% | 54.6% | 61.5% | 64.2% | 73.2% | 64.9% | 66.0% | |
| 9.4% | 8.0% | 8.8% | 8.1% | 8.0% | 8.0% | 8.2% | 8.4% | 8.3% | 7.7% | 8.2% | 7.9% | 8.0% | |
| 33.0% | 36.4% | 30.3% | 28.9% | 30.2% | 29.4% | 33.1% | 30.2% | 29.2% | 28.9% | 37.9% | 28.9% | 31.3% | |
| 60.5% | 62.6% | 522.6% | 54.4% | 55.2% | 54.1% | 59.5% | 49.4% | 53.7% | 51.9% | 68.9% | 53.2% | 57.0% | |
| -0.1% | -0.1% | -460.6% | 9.6% | 6.1% | 9.2% | 2.4% | 5.1% | 7.8% | 12.2% | 4.3% | 11.7% | 9.0% | |
| 1.7% | 3.5% | 3.2% | 4.9% | 5.2% | 4.5% | 4.1% | 3.7% | 4.7% | 4.7% | 4.1% | 3.9% | 4.3% | |
| -2.5% | 3.6% | -467.4% | 6.7% | 6.6% | -3.5% | 0.7% | 11.8% | 3.3% | 7.1% | -2.5% | 7.2% | 3.7% | |
| -0.2% | -0.3% | -35.2% | 0.9% | 0.7% | -0.9% | 12.2% | 3.8% | -0.8% | 1.5% | 4.0% | 2.5% | 1.8% | |
| -2.3% | 4.0% | -432.2% | 5.8% | 5.9% | -2.7% | -11.4% | 8.0% | 4.1% | 5.6% | -6.5% | 4.7% | 1.9% | |
| 14.4% | 24.0% | -453.5% | 21.0% | 22.3% | 9.7% | 16.9% | 25.5% | 17.6% | 20.5% | 6.5% | 20.6% | 16.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.